Literature DB >> 17878384

A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5.

Johan Duchene1, Florence Lecomte, Saleh Ahmed, Cecile Cayla, Joao Pesquero, Michael Bader, Mauro Perretti, Amrita Ahluwalia.   

Abstract

The kinin B1 receptor is an inducible receptor not normally expressed but induced by inflammatory stimuli and plays a major role in neutrophil recruitment, particularly in response to the cytokine IL-1beta. However, the exact mechanism involved in this response is unclear. The aim of this study was to dissect the molecular mechanism involved, in particular to determine whether specific ELR-CXCL chemokines (specific neutrophil chemoattractants) played a role. Using intravital microscopy, we demonstrated that IL-1beta-induced leukocyte rolling, adherence, and emigration in mesenteric venules of wild-type (WT) mice, associated with an increase in B1 receptor mRNA expression, were substantially attenuated (>80%) in B1 receptor knockout mice (B1KO). This effect in B1KO mice was correlated with a selective down-regulation of IL-1beta-induced CXCL5 mRNA and protein expression compared with WT mice. Furthermore a selective neutralizing CXCL5 Ab caused profound suppression of leukocyte emigration in IL-1beta-treated WT mice. Finally, treatment of human endothelial cells with IL-1beta enhanced mRNA expression of the B1 receptor and the human (h) CXCL5 homologues (hCXCL5 and hCXCL6). This response was suppressed by approximately 50% when cells were pretreated with the B1 receptor antagonist des-Arg9-[Leu8]-bradykinin while treatment with des-Arg9-bradykinin, the B1 receptor agonist, caused a concentration-dependent increase in hCXCL5 and hCXCL6 mRNA expression. This study unveils a proinflammatory pathway centered on kinin B1 receptor activation of CXCL5 leading to leukocyte trafficking and highlights the B1 receptor as a potential target in the therapeutics of inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878384      PMCID: PMC3696729          DOI: 10.4049/jimmunol.179.7.4849

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.

Authors:  Bysani Chandrasekar; Peter C Melby; Henry M Sarau; Muthuswamy Raveendran; Rao P Perla; Federica M Marelli-Berg; Nickolai O Dulin; Ishwar S Singh
Journal:  J Biol Chem       Date:  2002-12-04       Impact factor: 5.157

2.  Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury.

Authors:  Danielle G Souza; Eliane S L Lomez; Vanessa Pinho; João Bosco Pesquero; Michael Bader; Jorge Luís Pesquero; Mauro M Teixeira
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

Review 3.  Kinin B(1) receptors and the cardiovascular system: regulation of expression and function.

Authors:  P G McLean; M Perretti; A Ahluwalia
Journal:  Cardiovasc Res       Date:  2000-11       Impact factor: 10.787

4.  CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo.

Authors:  X W Zhang; Q Liu; Y Wang; H Thorlacius
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

5.  Isolation and characterization of mouse homolog of the neutrophil activating peptide-2.

Authors:  Masaaki Oda; Hirotaka Haruta; Masaya Nagao; Yuka Nagata
Journal:  Biochem Biophys Res Commun       Date:  2002-01-18       Impact factor: 3.575

6.  Tissue kallikrein is synthesized and secreted by human vascular endothelial cells.

Authors:  Katsutoshi Yayama; Naomi Kunimatsu; Yumiko Teranishi; Masaoki Takano; Hiroshi Okamoto
Journal:  Biochim Biophys Acta       Date:  2003-02-17

Review 7.  Cell-cell interactions: leukocyte-endothelial interactions.

Authors:  Thomas M McIntyre; Stephen M Prescott; Andrew S Weyrich; Guy A Zimmerman
Journal:  Curr Opin Hematol       Date:  2003-03       Impact factor: 3.284

8.  Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.

Authors:  Dai-Shi Su; M Kristine Markowitz; Robert M DiPardo; Kathy L Murphy; C Meacham Harrell; Stacy S O'Malley; Richard W Ransom; Raymond S L Chang; Sookhee Ha; Fred J Hess; Douglas J Pettibone; Glenn S Mason; Susan Boyce; Roger M Freidinger; Mark G Bock
Journal:  J Am Chem Soc       Date:  2003-06-25       Impact factor: 15.419

9.  SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.

Authors:  Jean Gougat; Bernard Ferrari; Lionel Sarran; Claudine Planchenault; Martine Poncelet; Jeanne Maruani; Richard Alonso; Annie Cudennec; Tiziano Croci; Fabio Guagnini; Katalin Urban-Szabo; Jean-Pierre Martinolle; Philippe Soubrié; Olivier Finance; Gérard Le Fur
Journal:  J Pharmacol Exp Ther       Date:  2004-01-27       Impact factor: 4.030

10.  Cardiac myocytes activated by septic plasma promote neutrophil transendothelial migration: role of platelet-activating factor and the chemokines LIX and KC.

Authors:  W Sean Madorin; Tao Rui; Naohito Sugimoto; Osamu Handa; Gediminas Cepinskas; Peter R Kvietys
Journal:  Circ Res       Date:  2004-02-26       Impact factor: 17.367

View more
  25 in total

Review 1.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

2.  Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors.

Authors:  Vanessa F Merino; Mihail Todiras; Luciana A Campos; Vera Saul; Elena Popova; Ovidiu C Baltatu; João B Pesquero; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2008-04-19       Impact factor: 4.599

3.  Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN.

Authors:  Peiqi Hu; Hua Su; Hong Xiao; Shen-Ju Gou; Carolina A Herrera; Marco A Alba; Masao Kakoki; Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2019-11-26       Impact factor: 10.121

Review 4.  Cross-talk between the complement and the kinin system in vascular permeability.

Authors:  Fleur Bossi; Ellinor I Peerschke; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Immunol Lett       Date:  2011-07-06       Impact factor: 3.685

5.  IL-1α modulates neutrophil recruitment in chronic inflammation induced by hydrocarbon oil.

Authors:  Pui Y Lee; Yutaro Kumagai; Yuan Xu; Yi Li; Tolga Barker; Chao Liu; Eric S Sobel; Osamu Takeuchi; Shizuo Akira; Minoru Satoh; Westley H Reeves
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

6.  Laminar shear stress regulates endothelial kinin B1 receptor expression and function: potential implication in atherogenesis.

Authors:  Johan Duchene; Cécile Cayla; Sandrine Vessillier; Ramona Scotland; Kazuo Yamashiro; Florence Lecomte; Irfan Syed; Phuong Vo; Alessandra Marrelli; Costantino Pitzalis; Francesco Cipollone; Joost Schanstra; Jean-Loup Bascands; Adrian J Hobbs; Mauro Perretti; Amrita Ahluwalia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

7.  Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.

Authors:  Yang Gao; Pengfei Lin; John P Lydon; Qinglei Li
Journal:  J Pathol       Date:  2017-08-07       Impact factor: 7.996

8.  CXCL5 limits macrophage foam cell formation in atherosclerosis.

Authors:  Anthony Rousselle; Fatimunnisa Qadri; Lisa Leukel; Rüstem Yilmaz; Jean-Fred Fontaine; Gabin Sihn; Michael Bader; Amrita Ahluwalia; Johan Duchene
Journal:  J Clin Invest       Date:  2013-02-08       Impact factor: 14.808

9.  Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Authors:  Dirk Westermann; Thomas Walther; Konstantinos Savvatis; Felcicitas Escher; Meike Sobirey; Alexander Riad; Michael Bader; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

10.  Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice.

Authors:  Koustav Ganguly; Swapna Upadhyay; Martin Irmler; Shinji Takenaka; Katrin Pukelsheim; Johannes Beckers; Eckard Hamelmann; Holger Schulz; Tobias Stoeger
Journal:  Part Fibre Toxicol       Date:  2009-12-02       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.